22 March 2024 - The Outcome Statement from the February 2024 DUSC meeting is now available.

The DUSC reviewed the utilisation of the following PBS listed medicines:

• Dupilumab - asthma
• Nivolumab and ipilimumab - mesothelioma
• Progesterone - pregnancy
• Romosozumab - osteoporosis

Read PBS News